About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Clinical Biochemistry
›
top-articles
Department of Clinical Biochemistry
131
(top 1%)
papers
4.6K
(top 1%)
citations
38
(top 1%)
h
-index
66
(top 1%)
g
-index
139
all documents
4.8K
doc citations
1.5K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension
European Heart Journal
2006
282
2
Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the greek atorvastatin and coronary-heart-disease evaluation (GREACE) study
American Journal of Kidney Diseases
2004
224
3
Harvesting the saphenous vein with surrounding tissue for CABG provides long-term graft patency comparable to the left internal thoracic artery: Results of a randomized longitudinal trial
Journal of Thoracic and Cardiovascular Surgery
2006
210
4
The Prevalence of Metabolic Syndrome in Various Populations
American Journal of the Medical Sciences
2007
181
5
The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions
Current Medical Research and Opinion
2005
165
6
Statin-fibrate combination therapy for hyperlipidaemia: a review
Current Medical Research and Opinion
2003
156
7
Different methods of creatinine measurement significantly affect MELD scores
Liver Transplantation
2007
142
8
Female Liver Transplant Recipients with the Same GFR as Male Recipients Have Lower MELD Scores?A Systematic Bias
American Journal of Transplantation
2007
139
9
The prevalence of the metabolic syndrome in Greece: The MetS-Greece Multicentre Study
Diabetes, Obesity and Metabolism
2005
134
10
Review article: renal function assessment in cirrhosis – difficulties and alternative measurements
Alimentary Pharmacology and Therapeutics
2007
128
11
Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients
Liver International
2011
120
12
Diagnosis and management of the metabolic syndrome in obesity
Obesity Reviews
2005
111
13
Adrenocortical dysfunction in liver disease: A systematic review
Hepatology
2012
110
14
Increased platelet aggregation and activation in peripheral arterial disease
European Journal of Vascular and Endovascular Surgery
2003
106
15
Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension
Respiratory Medicine
2003
93
16
Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications
Current Pharmaceutical Design
2007
87
17
Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study
Current Medical Research and Opinion
2004
84
18
Statins: An essential component in the management of carotid artery disease
Journal of Vascular Surgery
2007
79
19
Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease
Journal of Human Hypertension
2004
78
20
Treating to target patients with primary hyperlipidaemia:comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study)
Current Medical Research and Opinion
2006
63
21
Does Diabetes Mellitus Play a Role in Restenosis and Patency Rates Following Lower Extremity Peripheral Arterial Revascularization? A Critical Overview
Annals of Vascular Surgery
2008
61
22
Serum uric acid levels and risk for acute ischaemic nonembolic stroke in elderly subjects
Journal of Internal Medicine
2005
59
23
Cardiovascular risk stratification in familial hypercholesterolaemia
Heart
2016
59
24
The Combination of Nebivolol plus Pravastatin is Associated with a More Beneficial Metabolic Profile Compared to that of Atenolol plus Pravastatin in Hypertensive Patients with Dyslipidemia: A Pilot Study
Journal of Cardiovascular Pharmacology and Therapeutics
2003
58
25
Value of Thromboelastography in the Assessment of Platelet Function
Clinical and Applied Thrombosis/Hemostasis
2003
56
26
Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe
Current Medical Research and Opinion
2006
54
27
Smoking and Aortic Diseases
Circulation Journal
2007
53
28
The endothelin 1a receptor antagonist BSF 302146 is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein–carotid artery interposition grafts
Journal of Thoracic and Cardiovascular Surgery
2004
52
29
Coagulation, Platelets, and Acute Pancreatitis
Pancreas
2007
52
30
Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: Where we are now?
Platelets
2006
48
31
25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease
BMC Pulmonary Medicine
2012
47
32
Vascular risk factors in South Asians
International Journal of Cardiology
2008
46
33
Comparison of Total Cortisol, Free Cortisol, and Surrogate Markers of Free Cortisol in Diagnosis of Adrenal Insufficiency in Patients With Stable Cirrhosis
Clinical Gastroenterology and Hepatology
2014
45
34
Dyslipidaemia, Hypercoagulability and the Metabolic Syndrome
Current Vascular Pharmacology
2006
44
35
Epigenetic inactivation of endothelin‐2 and endothelin‐3 in colon cancer
International Journal of Cancer
2013
44
36
Antiplatelet agents for intermittent claudication
The Cochrane Library
2011
41
37
Endothelin‐1 stimulates colon cancer adjacent fibroblasts
International Journal of Cancer
2012
41
38
Definitions of Metabolic Syndrome: Where are We Now?
Current Vascular Pharmacology
2006
40
39
Endothelial function, arterial stiffness and lipid lowering drugs
Expert Opinion on Therapeutic Targets
2007
39
40
Could Statins Be Useful in the Treatment of Patients With Migraine?
Headache
2006
37
41
Statins and Solid Organ Transplantation
Current Pharmaceutical Design
2006
37
42
The Role of Endocannabinoid System Blockade in the Treatment of the Metabolic Syndrome
Journal of Clinical Pharmacology
2007
37
43
The Effect of Apolipoprotein E Polymorphism on the Response to Lipid-Lowering Treatment With Atorvastatin or Fenofibrate
Journal of Cardiovascular Pharmacology and Therapeutics
2006
35
44
Homocysteine Activates Platelets In Vitro
Clinical and Applied Thrombosis/Hemostasis
2008
35
45
Relationship between carotid atherosclerosis and coronary artery calcification in asymptomatic diabetic patients: A prospective multicenter study
Clinical Cardiology
2017
34
46
Dextran 40 reducesin vitroplatelet aggregation in peripheral arterial disease
Platelets
2004
33
47
Indirect Ion Selective Electrode Methods Potentially Overestimate Peritoneal Dialysate Sodium Losses
Therapeutic Apheresis and Dialysis
2014
32
48
The Management of Phosphodiesterase-5 (PDE5) Inhibitor Failure
Current Vascular Pharmacology
2006
31
49
Non-low-density lipoprotein cholesterol-associated actions of ezetimibe: an overview
Expert Opinion on Therapeutic Targets
2006
31
50
Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects
International Journal of Clinical Practice
2007
30
site/software ©
exaly
; All materials licenced under
CC by-SA
.